Vanesa Bijol (@vbijol) 's Twitter Profile
Vanesa Bijol

@vbijol

Kidney Pathologist

ID: 1067584623629221890

calendar_today28-11-2018 01:03:03

151 Tweet

1,1K Followers

167 Following

World Congress of Nephrology (@isnwcn) 's Twitter Profile Photo

𝗩𝗜𝗥𝗧𝗨𝗔𝗟 #ISNWCN Pre-Congress interview series. An inspiring interview with Int Society of Nephrology Council Member, Prof. Rümeyza Kazancıoğlu, MD, FISN by WCN'21 Social Media Team Member Urmila Anandh. 🎥 Full interview: youtu.be/5hHPd0pqMfQ 🖌️ Congress registration: theisn.org/wcn/registrati…

Astrid Weins (@astridweins) 's Twitter Profile Photo

While our paper is undergoing formal peer review, we decided to pre-publish a version of our manuscript on Medrxiv! Thanks to all our collaborators for their amazing work on this study! On to a new paradigm for MCD and FSGS! #bwhpath #bwhkidney medrxiv.org/content/10.110…

World Congress of Nephrology (@isnwcn) 's Twitter Profile Photo

And don't forget to attend the 𝗩𝗜𝗥𝗧𝗨𝗔𝗟 #ISNWCN live Q&A session during the Renal Pathology Course with OUH, Vanesa Bijol, Agnes Fogo, Wesam Ismail, Carmen Avila, and Virginie Royal. 🗓️ April 15, 2021 🕥 10:30 am EST cm.theisn.org/cmPortal/searc…

Azra Bihorac (@azrabihorac) 's Twitter Profile Photo

Excited to speak about #AIEthics tomorrow and Monday at #ISNWCN! I will be discussing artificial intelligence for augmented decision making in medicine.

Excited to speak about #AIEthics tomorrow and Monday at #ISNWCN! I will be discussing artificial intelligence for augmented decision making in medicine.
Astrid Weins (@astridweins) 's Twitter Profile Photo

Evidence of anti-nephrin in a podocytopathy with early segmental sclerosis (Caucasian patient). Don’t tell me that MCD/FSGS are not on the same spectrum. Let’s move away from pure morphologic classifications and get to the bottom of progression factors in this autoimmune disease.

Evidence of anti-nephrin in a podocytopathy with early segmental sclerosis (Caucasian patient). Don’t tell me that MCD/FSGS are not on the same spectrum. Let’s move away from pure morphologic classifications and get to the bottom of progression factors in this autoimmune disease.
GlomCon (@glomcon) 's Twitter Profile Photo

Why is XYZ A GlomCon Special by Dr. Helmut Rennke Episode 1 on Hypertensive Nephrosclerosis glomcon.zoom.us Mtng ID: 937 9592 6539 Passcode 202122 sign up for the newsletter glomcon.us13.list-manage.com/subscribe?u=aa…

Why is XYZ

A GlomCon Special by Dr. Helmut Rennke

Episode 1 on Hypertensive Nephrosclerosis

glomcon.zoom.us
Mtng ID: 937 9592 6539
Passcode 202122

sign up for the newsletter
glomcon.us13.list-manage.com/subscribe?u=aa…
Sayna Norouzi, MD, FASN (@saynanorouzi) 's Twitter Profile Photo

Officially starting the second year of online glomerular diseases fellowship program GlomCon. Super excited to work with this amazing group of colleagues from all around the world 🌎🎊🍾 #Nephtwitter #medtwitter Poyan Mehr Harish Seethapathy Vanesa Bijol

Officially starting the second year of online glomerular diseases fellowship program <a href="/GlomCon/">GlomCon</a>. 
Super excited to work with this amazing group of colleagues from all around the world 🌎🎊🍾 #Nephtwitter #medtwitter <a href="/poyanmehr/">Poyan Mehr</a> <a href="/BetterCallSeeth/">Harish Seethapathy</a> <a href="/VBijol/">Vanesa Bijol</a>
Iain Bressendorff, MD PhD (@ibressendorff) 's Twitter Profile Photo

This is the most incredible paper I have read in a long time. The story of the initial spark, the correlation to pemphigus, the collaborative effort, and the profound significance… I nominate this for paper of the year 2021 Astrid Weins #NephJCKidneys jasn.asnjournals.org/content/early/…

GlomCon (@glomcon) 's Twitter Profile Photo

This will be an eye opening 👁👁 session, is an understatement Presented by Dr Nast and moderated by Dr Bijol Vanesa Bijol Come and 🧐 for yourself

Tejas Desai, MD, MBA (@nephondemand) 's Twitter Profile Photo

3/ This team also highlights the need to identify patients *at risk* for CKD at the time of a nephrectomy. See the work of Kenar Jhaveri Vanesa Bijol purva sharma & Yihe Yang Jyoti Baharani also covered CKD & RCC at the American Society of Nephrology #KidneyWk meeting. sites.google.com/view/nephrowor…

3/
This team also highlights the need to identify patients *at risk* for CKD at the time of a nephrectomy. See the work of <a href="/kdjhaveri/">Kenar Jhaveri</a> <a href="/VBijol/">Vanesa Bijol</a> <a href="/purvasharma821/">purva sharma</a> &amp; <a href="/Yihe28745445/">Yihe Yang</a> 

<a href="/renalpages/">Jyoti Baharani</a> also covered CKD &amp; RCC at the <a href="/ASNKidney/">American Society of Nephrology</a> #KidneyWk meeting.

sites.google.com/view/nephrowor…